Bispecific antibody pipeline moves beyond oncology

The FDA is currently reviewing Roche’s bispecific antibody emicizumab for the treatment of haemophilia A…

Fonte: Nature Reviews Drug Discovery | Published online 29 Sep 2017

Para acessar a publicação na íntegra clique  aqui